IGC
IGC Pharma·AMEX
--
--(--)
--
--(--)
IGC Filings
Filing Date
Form Description
Form Type
2026-03-18
Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]
Financials
2026-03-18 · Financials
Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]
2026-03-12
Form 8-K - Current report
Key Events
2026-03-12 · Key Events
Form 8-K - Current report
2026-02-04
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-02-04 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-20
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-20 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-06
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-01-06 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-01-06
Form 8-K - Current report
Key Events
2026-01-06 · Key Events
Form 8-K - Current report
2026-01-02
Form 8-K - Current report
Key Events
2026-01-02 · Key Events
Form 8-K - Current report
2025-12-15
Form 8-K - Current report
Key Events
2025-12-15 · Key Events
Form 8-K - Current report
2025-12-08
Form EFFECT - Notice of Effectiveness
2025-12-08 ·
Form EFFECT - Notice of Effectiveness
2025-12-03
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
2025-12-03 ·
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
